Indian Tax Turbulence Dents Alembic In Q1 - Portends Industry Trend?

Alembic Pharmaceuticals’ first quarter earnings were weighed down by transitional disturbances pertaining to India’s new goods and services tax (GST) regime, potentially signaling an industry-wide trend, although likely temporary.